Summary & Overview
CPT 52235: Cystoscopic Destruction of Medium Bladder Lesion
CPT code 52235 denotes a transurethral cystoscopic procedure to inspect the urethra and bladder and to destroy medium bladder lesions measuring between 2.0 cm and 5.0 cm by fulguration, cryosurgery, or laser. This code captures a common minimally invasive urologic intervention used to manage symptomatic bladder tumors or other focal bladder lesions and is relevant to surgical, oncology, and urology service lines. Nationally, appropriate coding for 52235 affects facility and professional payments, quality measurement, and tracking of urologic procedural volume.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find context on the clinical intent of the code, typical sites of service, and which clinical scenarios generate use of this CPT code. The publication also provides benchmarking context for utilization and reimbursement patterns, notes common billing considerations, and summarizes policy or coverage trends that influence payment and prior authorization practices. Data not available in the input for specific payer rates, ICD-10 mappings, or related codes will be identified where relevant.
Billing Code Overview
CPT code 52235 describes a cystoscopic procedure in which the provider inspects the urethra, prostatic urethra (in men), the interior of the bladder, and ureteric openings using a cystoscope passed through the urethra into the bladder, and destroys (fulgurates) medium lesions between 2.0 cm and 5.0 cm using high–intensity electric current, cryosurgery, or laser surgery.
-
Service type: Endoscopic operative procedure for bladder lesion destruction (transurethral cystoscopic fulguration/ablation).
-
Typical site of service: Hospital outpatient department or ambulatory surgery center; may also be performed in an office setting with appropriate endoscopic and surgical capabilities.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 68-year-old man with a history of intermittent gross hematuria and a recently visualized bladder lesion on outpatient cystoscopy. The patient presents for operative cystoscopy with endoscopic fulguration of a medium-sized papillary bladder tumor identified on prior cystoscopy and imaging. Preoperative workflow includes history and physical, informed consent discussing risks of bleeding, urinary retention, infection, and possible need for conversion to transurethral resection or open surgery. On the day of service, the patient is brought to the ambulatory surgery unit or hospital operating room under monitored anesthesia care or general anesthesia. A rigid or flexible cystoscope is passed through the urethra to inspect the urethra, prostatic urethra, bladder interior, and ureteral orifices. The provider identifies one or more lesions measuring between 2.0 cm and 5.0 cm and treats them by fulguration using electrocautery, laser, or cryotherapy. Intraoperative documentation includes size and number of lesions, anatomic location, energy modality used, completeness of destruction, estimated blood loss, and any complications. Post-procedure workflow includes recovery in PACU, post-op instructions about catheter use and hematuria expectations, pathology if tissue obtained, and scheduled follow-up cystoscopy for surveillance per urologic guidelines.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Normal or routine service | When the procedure is the primary planned service performed by the reporting surgeon. |